Quality specifications for cardiac troponin assays

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 2, 2001, Pages 175-179

  Panteghini, M ^a   Gerhardt, W ^a   Apple, F S ^a   Dati, F ^a   Ravkilde, J ^a   Wu, A H ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

IFCC; Immunoassay; Myocardial infarction; Quality specifications; Recommendations; Troponin I; Troponin T

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T;

ANALYTIC METHOD; ARTICLE; ASSAY; CLINICAL LABORATORY; COMMUNITY; CONTROLLED STUDY; DOCUMENTATION; HEART; IMMUNOCHEMISTRY; INFORMATION; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUALITY CONTROL; TECHNIQUE;

EID: 0035052773     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/cclm.2001.39.2.175     Document Type: Article

References (27)

1. National academy of clinical biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases
2. Use of biochemical markers in acute coronary syndromes
3. Myocardial infarction redefined-A consensus document
4. Clinical and analytical standardization issues confronting cardiac troponin I
5. IFCC committee on standardization of markers of cardiac damage: Premises and project presentation
6. Proposals from the IFCC committee on standardization of markers of cardiac damage (C-SMCD): Strategies and concepts on standardization of cardiac marker assays
7. Present issues in the determination of troponins and other markers of cardiac damage
8. International survey of cardiac troponin users
9. Development and use of analytical quality specifications in the in vitro diagnostics medical device industry
10. Degradation of cardiac troponin I: Implication for reliable immunodetection
11. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I
12. Biochemical factors influencing measurement of cardiac troponin I in serum
13. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury
14. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays
15. New approach to standardization of human cardiac troponin I (cTnI)
16. Quantitative evaluation of linearity
17. Laboratory and near patient testing for cardiac markers
18. Functional sensitivity of cardiac troponin assays and implications for risk stratification
19. False increase of cardiac troponin I with heterophilic antibodies
20. High percentage of false positive cardiac troponin I results in patients with rheumatoid factor
21. Interference in immunoassay
22. Analytical interference. More than just a laboratory problem
23. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: Lower recoveries in early than in late phases of myocardial injury
24. Serum and plasma samples for ACS:Systems cardiac markers
25. False increases in troponin I attributable to incomplete separation of serum